Literature DB >> 7704597

Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: an in vivo microdialysis study.

J T Laitinen1, K S Laitinen, L Tuomisto, M M Airaksinen.   

Abstract

A microdialysis method combined with a sensitive radioimmunoassay was used to monitor extracellular cyclic GMP (cGMP) levels in the frontal cortex and the cerebellum of anesthetized rats in vivo. Basal cGMP release remained constant throughout the perfusion period and was approximately 2 fmol/30 min in the frontal cortex and approximately 4 fmol/30 min in the cerebellum. The nitric oxide (NO) donor sodium nitroprusside (SNP) stimulated cGMP release transiently in both regions. However, the maximal response was 3-fold in the frontal cortex (obtained with 5 microM SNP) but 90-fold in the cerebellum (obtained with 1 mM SNP). Perfusion with the NO synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) suppressed cerebellar cGMP release by 74% indicating that NO is the major regulator of basal cGMP levels in the cerebellum. Quite opposite, L-NAME exhibited no potency in the frontal cortex suggesting that other activators of guanylyl cyclase may regulate basal cortical cGMP levels in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7704597     DOI: 10.1016/0006-8993(94)90517-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex.

Authors:  Nicole L Roenker; Gary A Gudelsky; Rebecca Ahlbrand; Paul S Horn; Neil M Richtand
Journal:  Neuropharmacology       Date:  2012-05-09       Impact factor: 5.250

Review 2.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.